Another approach is the inhibitory targeting of proteins such as BRD4 (bromodomain-containing protein 4) recruited to the regulatory elements of the MYC gene, which can switch off the MYC-dependent leukemia sustainment program [236,242,243,244]. This evidence concerns the gene BRD4 and leukemia.